Patent · US Active

Polymorphic forms and process

US10307403B2 · kind B2 · utility

0Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2018
Grant dateJun 4, 2019
Priority date
Expiry dateNov 28, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/056
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a polymorph of a compound of formula (I)This polymorph is particularly suitable in treating IPF by pulmonary administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.